BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4951982)

  • 21. Long acting phenothiazines and long term psychotic patients: the role of fluphenazine enanthate in treatment.
    Wintrob RM
    Dis Nerv Syst; 1970 Sep; 31():Suppl:50-62. PubMed ID: 4990944
    [No Abstract]   [Full Text] [Related]  

  • 22. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI; Barron A; Kiriakos R
    J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
    [No Abstract]   [Full Text] [Related]  

  • 23. Experience with fluphenazine hydrochloride injection.
    Zabow T
    S Afr Med J; 1985 Jan; 67(4):118. PubMed ID: 3969594
    [No Abstract]   [Full Text] [Related]  

  • 24. A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients.
    van Praag HM; Breetveld J; van Mesdag-Etty H; Westerhuis R; Pen A; Schut T
    Psychiatr Neurol Neurochir; 1970; 73(3):165-75. PubMed ID: 4912332
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder.
    Lindenmayer JP; Khan A; Eerdekens M; Van Hove I; Kushner S
    Eur Neuropsychopharmacol; 2007 Jan; 17(2):138-44. PubMed ID: 17049818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
    Borenstein P; Dumaine A; Cujo P
    Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
    [No Abstract]   [Full Text] [Related]  

  • 27. [Out-patient treatment of psychoses using depot-fluphenazin].
    Schmidt P
    Psychiatr Neurol Med Psychol (Leipz); 1975 Apr; 27(4):231-8. PubMed ID: 1197460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluphenazine enanthate in the treatment of psychotic patients.
    Denzel HA
    Int J Neuropsychiatry; 1966 Jun; 2(3):258-61. PubMed ID: 5336047
    [No Abstract]   [Full Text] [Related]  

  • 29. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience in the management of chronic psychoses using fluphenazine-oenanthate].
    Eichstetter F
    Nervenarzt; 1968 Jun; 39(6):282-3. PubMed ID: 5712435
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electroencephalographic effects of fluphonazine decanoate].
    Borenstein P; Cujo P; Dumaine A
    Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine.
    Hanlon TE; Ota KY; Kurland AA
    Dis Nerv Syst; 1970 Mar; 31(3):171-7. PubMed ID: 4909632
    [No Abstract]   [Full Text] [Related]  

  • 33. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symposium on long-acting injectable fluphenazine preparations--a report.
    Cole JO
    Psychopharmacol Bull; 1969 Jan; 5(1):16-8. PubMed ID: 5797007
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is it possible to envisage the treatment of various potentially dangerous states with prolonged-action chemotherapy?].
    Boissenin JM; Staël P; Poiré R
    Ann Med Psychol (Paris); 1970 May; 128(5):776-81. PubMed ID: 5452656
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-acting risperidone in stable patients with schizoaffective disorder.
    Mohl A; Westlye K; Opjordsmoen S; Lex A; Schreiner A; Benoit M; Bräunig P; Medori R
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):22-31. PubMed ID: 16144783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A contribution to the maintenance therapy with depot neuroleptic drugs.
    Vencovský E; Peterová E; Baudis P; Janovský F
    Act Nerv Super (Praha); 1973 May; 15(2):84. PubMed ID: 4752676
    [No Abstract]   [Full Text] [Related]  

  • 38. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fluphenazine HCl in psychiatry].
    Ucha Udabe R
    Prensa Med Argent; 1965 Dec; 52(48):3004-5. PubMed ID: 5886578
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.